✦ LIBER ✦

Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a

✍ Scribed by Stefan Zeuzem; Eva Herrmann; Jung-Hun Lee; Jens Fricke; Avidan U. Neumann; Marlene Modi; Giuseppe Colucci; W. Kurt Roth

Book ID: 119756221
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 511 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1053/gast.2001.24006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[645] EARLY VIRAL KINETICS IN PATIENTS W

[645] EARLY VIRAL KINETICS IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 2 OR 3 TREATED WITH PEGINTERFERON o-2a AND RIBAVIRIN

✍ Th-M. Scherzer; K. Staufer; P. Steindl-Munda; H. Holzmann; P. Ferenci 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Durability of SVR in chronic hepatitis C

Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral

✍ Rutter, K.; Hofer, H.; Beinhardt, S.; Dulic, M.; Gschwantler, M.; Maieron, A.; L 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Peginterferon Alfa-2a in Patients with C

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

✍ Zeuzem, Stefan; Feinman, S. Victor; Rasenack, Jens; Heathcote, E. Jenny; Lai, Mi 📂 Article 📅 2000 🏛 Massachusetts Medical Society 🌐 English ⚖ 169 KB

575 Association between an index of stan

575 Association between an index of standard biochemical serum markers, viral kinetics, and therapeutic outcome with peginterferon α-2a combination therapy in patients with chronic hepatitis C

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Early hepatitis C virus changes and sust

Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon α-2b and ribavirin

✍ J. F. Gallegos-Orozco; A. Loaeza-del Castillo; A. P. Fuentes; M. García-Sandoval 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Hepatic steatosis in patients with chron

Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 or 24 weeks

✍ Maribel Rodriguez-Torres; Sugantha Govindarajan; Moises Diago; Thomas Morgan; Bh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB